1. Anomia in people with rapidly evolving severe relapsing-remitting multiple sclerosis: both word retrieval inaccuracy and delay are common symptoms. Issue 2 (1st February 2020) Authors: De Dios Pérez, Blanca; Cordova Luna, Erika; Cloutman, Lauren; Rog, David; Preston, Emma; Conroy, Paul Journal: Aphasiology Issue: Volume 34:Issue 2(2020) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1127 Pregnancy outcomes in alemtuzumab trials and registry design. (1st December 2017) Authors: Rog, David; Oh, Jiwon; Chambers, Christina; Fox, Edward J; McCombe, Pamela; Otero, Susana; Margolin, David H; Kasten, Linda; Compston, DAlastair S Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies. (July 2021) Authors: Oh, Jiwon; Vukusic, Sandra; Tiel-Wilck, Klaus; Inshasi, Jihad Said; Rog, David; Baker, Darren P; Pyatkevich, Yelena; Poole, Elizabeth M; Vermersch, Patrick Journal: Journal of central nervous system disease Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Issue 9 (September 2021) Authors: Brown, J William L; Cunniffe, Nick G; Prados, Ferran; Kanber, Baris; Jones, Joanne L; Needham, Edward; Georgieva, Zoya; Rog, David; Pearson, Owen R; Overell, James; MacManus, David; Samson, Rebecca S; Stutters, Jonathan; ffrench-Constant, Charles; Gandini Wheeler-Kingshott, Claudia A M; Moran, Ca... Journal: Lancet neurology Issue: Volume 20:Issue 9(2021) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 171 Alemtuzumab induced neutropaenia: women at risk. Issue 12 (14th November 2019) Authors: Tanveer, Riffat; Pace, Adrian; Rog, David; Nazar, Sharaf; Talbot, Paul; Jackson, Fran; Mihalova, Tatiana Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO141 Audit of the first line oral disease modifying treatments in greater manchester. (1st December 2017) Authors: Mihalova, Tatiana; Jackson, Fran; Lusher, William; Pace, Adrian; Sharaf, Naz; Rog, David; Talbot, Paul Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis. (9th November 2021) Authors: Jandric, Danka; Lipp, Ilona; Paling, David; Rog, David; Castellazzi, Gloria; Haroon, Hamied; Parkes, Laura; Parker, Geoff J.M.; Tomassini, Valentina; Muhlert, Nils Journal: Neurology Issue: Volume 97:Number 19(2021) Page Start: e1886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register. (June 2022) Authors: Garjani, Afagh; Hunter, Rachael; Law, Graham R; Middleton, Rodden M; Tuite-Dalton, Katherine A; Dobson, Ruth; Ford, David V; Hughes, Stella; Pearson, Owen R; Rog, David; Tallantyre, Emma C; Nicholas, Richard; Morriss, Richard; Evangelou, Nikos; das Nair, Roshan Journal: Multiple sclerosis Issue: Volume 28:Number 7(2022) Page Start: 1060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022) Authors: Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu... Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 110 UK multiple sclerosis service audit of 70 centres: MS-MDTs. Issue 6 (27th May 2022) Authors: Rog, David; Hobart, Jeremy; Mathews, Joela Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗